
    
      This is a randomized, double-masked, comparative study versus Systane ultra UD, to evaluate
      the efficacy and safety of LO2A eye drops for symptomatic improvement of dry eye in Patients
      with Sj√∂gren's syndrome. Eligible patients will be randomly assigned in a 1:1 ratio to one of
      two treatment groups, LO2A or Systane ultra UD, respectively.

      The study will consist of a screening period of up to two weeks and a 3-month double blind
      treatment period (topical application of eye drops four times daily)

      Up to 60 subjects are planned to be recruited to this study, randomized to one of two
      treatment arms using a 1:1 active (LO2A) to Systane ultra UD ratio.
    
  